Europe Urethral Bulking Systems Market
Europe Market Study on Urethral Bulking Systems: Demand for Pyrolytic Carbon-coated Graphite Beads to Remain High
Europe Urethral Bulking Systems Market Segmented By Pyrolytic Carbon-coated Graphite Beads, Calcium Hydroxylapatite-based, Polydimethylsiloxane Macroparticle, Polyacrylamide Hydrogel, Hyaluronic Acid-based Product
Demand for urethral bulking systems in Europe is projected to increase at a CAGR of 6% from 2021 to 2031. As per Persistence Market Research’s projections, pyrolytic carbon-coated graphite beads accounted for a substantial share of over 55% of the overall market in 2020.
Find Out More about the Report Coverage
- Boston Scientific Corporation
- Coloplast Corporation
- Axonics Modulation Technologies, Inc. (Contura, Inc.)
- Palette Life Sciences, Inc.
- Laborie, Inc.
Key Insights Covered in Urethral Bulking Systems Industry Survey:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis By Key Players
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Demand for Urethral Bulking Systems and How to Navigate
- Recommendation on Key Winning Strategies
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Demand Analysis of Urethral Bulking Systems in Europe from 2016 to 2020 Vs Projected Market Outlook for 2021 to 2031
Demand for urethral bulking systems rose at 4.9% CAGR over the past 5 years in Europe.
Awareness regarding urinary incontinence treatment is increasing among the population. Embarrassment, stress, and discomfort related to female urinary incontinence, especially in social gatherings, are considered major concerns for stress urinary incontinence patients.
Rise in awareness through several initiatives by the World Health Organization, various NGOs, and other healthcare associations worldwide has boosted the acceptance of female stress urinary incontinence condition and treatment options available for women around the globe. Adoption of these devices is expected to increase rapidly over the coming years.
The European market for urethral bulking systems is expected to expand at a considerable growth rate over the next ten years at a CAGR of around 6. Demand for treatment will remain high throughout the mentioned period.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
What are the Key Opportunities for Manufacturers of Urethral Bulking Systems in Europe?
Polyacrylamide hydrogel for urethral bulking systems presents strong growth opportunities. This bulking agent is injected into the urethral submucosa using a specifically designed injecting device. Clinical trials have shown that this bulking agent has the least injection site reactions.
Explore Persistence Market Research’s expertise in promulgation of the business !
What is Restraining Demand for Urethral Bulking Systems in the Continent?
Various complications related to urethral bulking systems such as sub urethral abscess, urethral prolapse, and particle migration may affect the adoption of these products, thereby restraining demand during the forecast year from 2021 to 2031.
Furthermore, presence of other treatment options such as surgery and drug therapy that are also well established could restrict product adoption over the coming years.
What Makes the Germany a Leading Market for Urethral Bulking Systems in Europe?
Germany is estimated to dominate the European region with a total market share of over 20% in 2021, and the market is projected to grow significantly throughout the forecast period. This growth is driven by rapid rise in the ageing female population in the country.
What Share Does the U.K Hold in the European Market for Urethral Bulking Systems?
In 2020, the U.K. accounted for a 13.8% share in the European market, and this market is projected to expand at a CAGR of 6.8% from 2021 to 2031. Advancements in technology is one of the factors attributed to the growth of the market in this country.
Which Product is Driving Market Growth for Urethral Bulking Systems?
By product, pyrolytic carbon-coated graphite beads will lead the market throughout the forecast period with a projected share of 55% in 2031. High demand for the product is due to the cost-effectiveness and fewer side effects associated with them.
Which is the Leading End User of Urethral Bulking Systems in Europe?
Based on end user, hospitals is the leading segment with a projected market share of 68% in 2031. However, with growth in the adoption of the treatment procedure for urinary incontinence, other end user segments are also expected to gain traction over the years to come.
What is the Impact of COVID-19 on Demand for Urethral Bulking Systems?
COVID-19 is anticipated to have a moderately negative impact on the demand for urethral bulking systems in Europe. This is mainly due to lockdowns and temporary shutdown of economies and industries. With the spread of coronavirus crisis, healthcare providers are shifting their priorities toward measures that are meant to overcome pandemic.
Stress urinary incontinence treatment is considered a non-emergency procedure and a lot of treatments have been postponed during the pandemic. Patients have been avoiding hospital and clinic visits to prevent the spread of infection. This has resulted in stagnant growth during the second and third quarters of 2020.
However, economies opening up again post the 2nd wave has created an opportunity for the market to regain its lost demand.
What is the Impact of Market Consolidation on the Urethral Bulking Systems Business Space?
Considering the consolation activities in the European market for urethral bulking systems, mergers acquisitions have emerged as one of the key growth strategies. Prominent manufacturers of urethral bulking systems are strengthening their product ranges through acquisitions and reaching out to key as well as emerging markets.
- In February 2021, Axonics Modulation Technologies, Inc. acquired UK-based Contura and its lead product Bulkamid, which is a urethral bulking agent that is used in the treatment of female stress urinary incontinence (SUI).
- In April 2019, Laborie, Inc. acquired Cogentix Medical to expand its product portfolio and strengthen its overactive bladder and stress urinary incontinence segment.
Key players are focusing strategies such as expansion, new product launches and approvals, agreements, partnerships, collaborations, and developing their distribution channels, such as online sales, to further strengthen their market presence.
- In June 2019, Boston Scientific Corporation unveiled the expansion of a new Equipment Technology Centre at its Ballybrit site in Galway.
- In March 2021, Axonics Modulation Technologies, Inc., signed an agreement to produce a neuromodulation device with Micro Systems Technologies.
Similarly, recent developments related to companies manufacturing urethral bulking systems have been tracked by the team at Persistence Market Research, which are available in the full report.
Urethral Bulking Systems Market Report Scope
Historical Data Available for
US$ Mn for Value
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Available upon Request
Key Segments Covered in Urethral Bulking Systems Industry Research
- Pyrolytic Carbon-coated Graphite Beads
- Calcium Hydroxylapatite-based
- Polydimethylsiloxane Macroparticle
- Polyacrylamide Hydrogel
- Hyaluronic Acid-based
By End User
- Urethral Bulking Systems for Hospitals
- Urethral Bulking Systems for Ambulatory Surgical Centers
- Urethral Bulking Systems for Specialty Clinics
- FAQs -
Revenue from the Europe urethral bulking systems market is estimated to be valued at US$ 22.3 Mn at present.
The European market for urethral bulking systems is expected to reach a value of US$ 40 Mn by the end of 2031, with sales revenue expected to register a CAGR of 6% over the same period.
From 2016-2020, sales of urethral bulking systems across Europe registered a CAGR of 4.9%, on the back of rising incidence of urinary disorders during the period.
Growth of the market has been benefitted from a shift towards non-particulate urethral bulking agents due to their high efficacy and promising results.
Germany, Italy, and the U.K. are expected to drive demand for urethral bulking systems in Europe.
Germany is one of the dominant markets for urethral bulking system production and sales. The country is expected to account for over 20% of the European market in 2031.
Demand for urethral bulking systems is anticipated to register a growth rate of 6% across the European region during the forecast period.
Sales of urethral bulking systems in France and Spain are expected to witness growth of 6.4% and 5.9% CAGRs, respectively.